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Abstract
Background: Therapy with mesenchymal stem cells (MSCs) has been reported to provide beneficial effects in the
treatment of neurological and orthopaedic disorders in dogs. The exact mechanism of action is poorly understood.
Magnetic resonance imaging (MRI) gives the opportunity to observe MSCs after clinical administration. To visualise
MSCs with the help of MRI, labelling with an MRI contrast agent is necessary. However, it must be clarified whether
there is any negative influence on cell function and viability after labelling prior to clinical administration.
Results: For the purpose of the study, seven samples with canine adipose-derived stem cells were incubated with
superparamagnetic iron oxide nanoparticles (SPIO: 319.2 μg/mL Fe) for 24 h. The internalisation of the iron particles
occurred via endocytosis. SPIO particles were localized as free clusters in the cytoplasm or within lysosomes depending
on the time of investigation. The efficiency of the labelling was investigated using Prussian blue staining and
MACS assay. After 3 weeks the percentage of SPIO labelled canine stem cells decreased. Phalloidin staining
showed no negative effect on the cytoskeleton. Labelled cells underwent osteogenic and adipogenic differentiation.
Chondrogenic differentiation occurred to a lesser extent compared with a control sample. MTT-Test and wound
healing assay showed no influence of labelling on the proliferation. The duration of SPIO labelling was assessed
using a 1 Tesla clinical MRI scanner and T2 weighted turbo spin echo and T2 weighted gradient echo MRI
sequences 1, 2 and 3 weeks after labelling. The hypointensity caused by SPIO lasted for 3 weeks in both
sequences.
Conclusions: An Endorem labelling concentration of 319.2 μg/mL Fe (448 μg/mL SPIO) had no adverse effects on the
viability of canine ASCs. Therefore, this contrast agent could be used as a model for iron oxide labelling agents. However,
the tracking ability in vivo has to be evaluated in further studies.
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Background
The use of stem cells is becoming increasingly important
in veterinary medicine. Mesenchymal stem cells (MSCs)
have been shown to improve tissue repair in oral ulcers
[1, 2] and bone defects [3–6], as well as in dogs with
osteoarthritis of the coxofemoral and elbow joint [7–10].
MSCs have also been used in canine central nervous
system to treat spinal cord injury [11–14] and ischemic
brain infarction [15].
There is still little information about the exact
mechanism of action of MSCs. The behaviour of the
MSCs during the stem cell therapy can be examined
non-invasively by magnetic resonance imaging (MRI).
However, labelling of the stem cells is required in
order to distinguish administered cells from the host
tissue. A couple of intracellular strategies have been
suggested to label MSCs [16–19]. One of them is
based on the use of superparamagnetic iron oxide
particles (SPIO). The advantage of SPIO particles is
that they are taken up via endocytosis as well as by
nonphagocytic cells and there is no need for a trans-
fection agent [18, 20, 21]. A commercially available
MRI contrast agent that contains a dextran coated
SPIO formulation—ferrumoxides—is known under
the name Endorem (Guerbet). Endorem affects the
T2 relaxation time by inducing a strong field in-
homogeneity, leading to a signal decrease as a result
of the susceptibility changes in the tissues containing
Endorem.
However, it is still unclear whether Endorem labelling
has a negative influence on canine MSCs’ viability, pro-
liferation, cytoskeleton and differentiation potential. An-
other question concerns the duration of the labelling
and the amount of contrast agent necessary to preserve
detectability of the MSCs via MRI.
This study was designed to prospectively investi-
gate the growth behaviour and MRI signal properties
of adipose-derived canine stem cells (ASCs) after la-
belling with the MRI contrast agent Endorem using
1 Tesla MRI in vitro. The use of 1 Tesla MRI to
detect Endorem labelled cells could enable routine
examination after stem cell therapy in veterinary
clinical practice to verify correct implantation and
further distribution of the MSCs.
Methods
Isolation of canine mesenchymal stem cells
MSCs were isolated as previously reported [22] from
intraabdominal or subcutaneous adipose tissue that
was harvested from seven dogs during routine surgi-
cal procedures. Fat was removed in order to improve
the intraoperative visibility of other organs and was
supposed to be disposed. All dogs were free of sys-
temic diseases.
Labelling of adipose derived mesenchymal stem cells
To assess the optimal labelling concentration of Endorem,
three different concentration were tested (10 μL (SPIO =
158 μg/mL; Fe = 112 μg/mL), 28.35 μl (SPIO = 448 μg/mL;
Fe = 319.2 μg/mL) and 40 μL (SPIO = 632.4 μg/mL; Fe =
448 μg/mL). These concentrations were chosen according
to the results of the doctoral thesis of Kruttwig (2009). An
Endorem concentration of 28.35 μL in 1 mL of medium
labelled most of the ASCs without comprising their spindle
morphology. After labelling with the respective concen-
trations the live cell imaging observations remained un-
changed. For this reason an Endorem concentration of
28.35 μL was used in the present study. ASCs (150 000
cells) were incubated with Endorem at a concentration
of 28.35 μl/mL (SPIO = 448 μg/mL; Fe = 319.2 μg/mL)
for 24 h.
Prussian blue staining (PB)
PB staining was performed on all seven samples
3 days, 1, 2 and 3 weeks after Endorem labelling to
evaluate if SPIO were incorporated into the cells.
Number of blue iron inclusions within the cells at all
time intervals was assessed to set a reference value.
After incubation the cells were fixed with 4% parafor-
maldehyde (PF). The PB solution was prepared by
mixing 3 mL of 2% potassium ferrocyanide (II)
(Merck) with the same amount of 1% hydrochloric
acid (Merck). The stain was then put on the cells at
room temperature for 20 min. Nuclear fast red-
aluminum sulphate staining was performed to colour
the nuclei. All of the stained samples were then eval-
uated under a microscope (Axiophot, Zeiss) at 12.5x
magnification.
Magnetic activated cell sorting (MACS)
MACS cell separation was undertaken to assess the effi-
ciency of the labelling. A MiniMACS separator (Miltenyi
Biotec) was used to sort the labelled from unlabelled cell
population 1, 2 and 3 weeks after labelling using MS
Column guidance (Miltenyi Biotec). After centrifugation
both fractions of cells were counted using a Neubauer
cell chamber (Marienfeld) to evaluate the percentage of
each fraction.
Phalloidine staining (PS)
PS was performed with all samples 1 week after la-
belling. The distribution and integrity of the actin
filaments of labelled cells was compared to that of
unlabelled cells. Seven days after Endorem labelling,
the labelled and unlabelled cells were fixed with 4%
PF and permeabilized with 1% Triton (Serva). The
cytoskeleton was stained with phalloidine (Sigma-Aldrich)
and the nuclei contra-stained with Hoechst-33342
(Invitrogen). Fluorescence micrographs were taken with
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an Axio Observer 2.1 (Zeiss) and a Leica Camera under
100- and 400× magnification.
Transmission electron microscopy (TEM)
TEM was performed on four samples to assess the intra-
cellular location of Endorem particles. Unlabelled and
labelled ASCs 1 and 3 (two samples) or 2 and 3 weeks
(two samples) after Endorem labelling were investigated.
After incubation in a Chamber Slide System (Thermo
Fischer) unlabelled and labelled ASCs were fixed with
Yellow-Fix (2% glutaraldehyde (Agar Scientific), 2% PF,
and 0.02% picric acid (Fluka Analytical)), then postfixed
with 1% osmium solution (Carl Roth). The samples were
dehydrated with ethanol (Merck) and embedded in Epon
(Serva). Ultrathin sections (70–90 nm) were stained with
lead citrate and uranyl acetate (Leica microsystems), col-
lected on copper grids and examined under a TEM 109
(Zeiss). Pictures were taken using a digital camera (Leica
Camera DFC320, Leica microsystems).
Investigation of the influence of Endorem labelling on the
multipotency of adipose derived stem cells
Adipogenic differentiation
For the evaluation of adipogenic differentiation, samples
from two dogs were investigated. ASCs were divided into
three groups: labelled, unlabelled and negative control
cells. Both labelled and unlabelled cells were incubated in
adipogenic medium (DMEM low glucose, Gibco life tech-
nologies), 10% FBS (PAA), 1% penicillin/streptomycin
(AppliChem), 0.1 μM dexamethasone (Sigma Aldrich),
5 μg/mL ITS (Sigma Aldrich), 0.2 mM indomethacin
(Sigma Aldrich) and 0.5 mM IBMX (Sigma Aldrich) for
2 weeks, while negative control cells were incubated in the
standard medium. After this time the cell population was
fixed in 4% PF and red oil O staining was performed. The
nuclei were stained with hematoxyline (Merck) for 10 s.
The glass slides with the stained cells were embedded
in Kaiser’s glycerol gelatine (Merck) and examined
by light microscopy (Leica camera 090135006; Leica
Microsystems).
Osteogenic differentiation
For the assessment of osteogenic differentiation, two
samples were investigated. ASCs were divided as with
the adipogenic differentiation into three groups. The la-
belled and unlabelled cell fractions were incubated in an
osteogenic medium (DMEM low glucose, 10% FBS, 1%
penicillin/streptomycin, 0.1 μM dexamethasone, 10 mM
ß-glycerol phosphate (Sigma Aldrich), 0.06 mM ascorbic
acid (Sigma Aldrich)) for 3 weeks, while the cells of the
negative control were incubated in the standard
medium. After fixation with 4% PF, von Kossa staining
was performed. Cells were incubated in a 5% silver
nitrate solution (Merck) for 30 min and then with 5%
natrium carbonate formaldehyde solution (Merck) for
5 min. After an incubation with Farmer’s reducer for
30 s, the nuclei were stained with nuclear fast red-
aluminium sulphate. Embedding was then performed
corresponding to adipogenic differentiation.
Chondrogenic differentiation
For the evaluation of chondrogenic differentiation potential,
two samples were investigated. ASCs were divided into
three groups: labelled, unlabelled and negative control cells.
Both the labelled and unlabelled cells were incubated in
chondrogenic medium ((DMEM low glucose, 1% penicil-
lin/streptomycin, 0.1 μM dexamethasone, 10 μg/mL ITS
(Sigma Aldrich), 0.9 mM natrium pyruvate (Sigma Aldrich),
0.17 mM ascorbic acid, 0.35 mM proline (Sigma Aldrich),
TGF – ß (Sigma Aldrich)) for 4 weeks in 15 mL falcon
tubes, while negative control cells were incubated in
standard medium. After 4 weeks the entire cell popu-
lation was fixed in 4% PF, embedded in paraffin and
cut and stained with Alcian blue (Merck).
3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazoliumbromid
(MTT) test
MTT test was performed on two samples to assess the
influence of the Endorem labelling on the proliferation
of the labelled cells. Stem cells were seeded at a density
of 28 500 cells/ well in two 24 well plates. Half of the
cells were labelled with Endorem, then incubated for
24 h, second plate 48 h, respectively. After this time
0.5 mg/mL MTT solution (Sigma Aldrich) was added to
one of the plate for 4 h, then 200 μL DMSO (Applichem)
for 10 min. The absorption of the labelled and unlabelled
cells was measured with Tecan sunrise (Tecan) 24 and
48 h after labelling.
Wound healing and migration
Migration and Proliferation of the labelled and un-
labelled cells of 5 samples were further investigated
using 2 well Culture inserts system (IBIDI) according to
the guidelines. After 24 h incubation the culture insert
was removed. Life cell imaging (Zeiss) was used to
evaluate the “wound healing process” over 24 h. The
evaluation of the cell uncovered area was assessed using
Image J Software (National Institute of Health, USA)
every 3 h over 24 h period.
Investigation of labelling efficiency via MRI
For the investigation of the labelling efficiency a 1 Tesla
clinical MRI scanner (Gyroscan Intera, Philips Medical
Systems) was used. Endorem labelled cells from all seven
samples were placed into 0.5 ml 0.6% agar solution and
then in an agar phantom 1, 2 and 3 weeks after labelling.
The mean cell count was 1 800 857, 2 125 000, 2 538
928 for each week respectively. Additionally, a negative
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control containingagar gel solely, a positive control with
Endorem (concentration 28.35 μL/mL) and a control
with the positive contrast agent Dotarem (Guerbert)
were investigated. A horizontally oriented gradient echo
(T2w FFE) (field of view 140 mm, repetition time
200 ms, time of echo 21 ms, 17 slices, thickness 1.5 mm
/-0.9 mm, flip angle 30°) and a turbo spin echo sequence
(T2w TSE) (field of view 200 mm, repetition time
6000 ms, time of echo 71 ms, 14 slices, thickness
1.6 mm /-1 mm) were performed. The voxel size and
number of voxels per sample can be found in the Table 1.
For the relative estimation of the signal intensity a dedi-
cated software (View Forum R6.3V1L7 SP1 2010, Philips
Medical System) was used. The signal intensity was mea-
sured for every sample (agar with labelled cells, negative
control, agar with Endorem). For this purpose a region
of interest (ROI) of 24 mm2 was placed in every sample.
A graph illustrates the signal intensity and its frequency
within every sample and also maximal, minimal and
mean values including the standard deviation (Fig. 1).
Statistical analysis
One-way analysis of variance with repeated measurements
was performed to assess the decrease in the labelled cells
in the MACS test over 3 weeks. To determine reference
values of the labelled cells 1, 2 and 3 weeks after labelling
in the MACS test and the value of the number of
Endorem particles in a single cell in the Prussian blue
staining, a 95% confidence interval was calculated.
Influence of Endorem labelling in the migration und
wound healing assay was performed using t-test. Further,
the influence of the cell line on the wound healing
process was assessed using Pearson correlation test.
The development of the signal intensity of the labelled
cells in MRI was assessed with 2-way analysis of variance
(ANOVA) with repeated measurements with respect to
the MRI sequence and the point in time.
Furthermore, correlation analysis with the Pearson’s
correlation coefficient was performed between the signal
intensities of both MRI sequences and the MACS test
for 1, 2 and 3 weeks after labelling.
Results
Isolation of ASCs and efficiency of Endorem labelling in
the Prussian blue staining and MACS assay
ASCs could be easily isolated from canine adipose tissue.
After 24 h incubation plastic adherent cells with fibro-
blastic morphology could be observed. Three days after
labelling with PB there were numerous blue iron inclu-
sions visible within the cells (Fig. 2a). An Endorem con-
centration of 448 μg/mL SPIO was sufficient to visually
label all cells within 24 h. Iron particles were still
detectable in the cells 3 weeks after labelling with
Endorem (Fig. 2d). The iron particles were not
equally subdivided to the daughter cells during cell
division. It was not possible to set a reference value
of iron particles within a single cell at time intervals
of three, seven, fourteen and twenty one days with a
95% confidence interval calculation.
In the MACS assay, one week after labelling the la-
belled cells accounted for: 92.36%, 91.28%, 92.78%,
87.5%, 84.04%, 46.3% and 25.4% of all cells in samples
one – seven, respectively; 2 weeks after labelling:
70.71%, 70.2%, 71.64%, 62.27%, 61.97%, 32.4%, 18.3%;
and 3 weeks after labelling: 68.79%, 78.53%, 59%, 73.4%,
20.33%, 27.7%, 11.1%. It was not possible to determine
reference values of the percentage of labelled cells for
the time intervals of 1, 2 and 3 weeks.
Influence of the Endorem labelling on the cytoskeleton
A comparison of the integrity and distribution of actin
filaments in the labelled and unlabelled cells under 100
and 400 times magnification revealed no alterations
(Fig. 3a, b).
Transmission electron microscopy (TEM) examination:
distribution of the Endorem particles within the cell
Under TEM, SPIO particles were seen within the cells
and also within vesicles outside the cells (Fig. 4 a-d).
The moment of endocytosis of SPIO into the cell and
formation of a membrane vesicle could also be captured
(Fig. 4 a). One and two weeks after labelling the iron
clusters were mainly visible within the cytoplasm with-
out compartmentalisation (Fig. 4 b, c). In week 3 the
Endorem particles were basically detected in lysosomes
(Fig. 4d).
Influence of the Endorem labelling on multipotency,
proliferation and viability
Multipotency was assessed on the basis of adipogene-
sis, chondrogenesis and osteogenesis. Labelled and
unlabelled cells incubated with adipogenic medium
underwent adipogenic differentiation. Red Oil O
stained cells showed multiple red fat vacuoles inside
the cells (Fig. 5a, b). Labelled cells also underwent
normal osteogenic differentiation. Under von Kossa
Table 1 Acquired, reconstructed voxel size (mm) and number of voxels per sample (24 mm2)
Sequence Acquired Voxels (mm) Reconstructed Voxels (mm) Voxels per sample (24 mm2)
T2FFE 0.55 x 0.55 x 1.5 0.55 x 0.55 x 1.5 43.64
T2wTSE 0.69 x 0.82 x 1.6 0.69 x 0.69 x 1.6 34.78
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staining, black stained precipitates in the extracellular
matrix could be observed (Fig. 6a, b). The cell bodies
also showed a black staining pattern. The control
group exhibited no signs of mineralisation (Fig. 6c). In
contrast to this, less labelled cells underwent chondro-
genic differentiation comparing to the control (Fig. 7b).
Interestingly, the negative control also showed signs of
chondrogenesis (Fig. 7c).
In MTT test both samples 48 h after labelling showed
a higher absorbance (unlabelled cells: sample one: 0.613;
0.480; 0.539; sample two: 0.501; 0.520; 0.486; labelled
cells: sample one: 0.786; 0.723; 0.712; sample two: 0.506;
0.396; 0.416) compared to samples 24 h after labelling
(unlabelled cells: sample one: 0.079; 0.076; 0.071; sample
two: 0.087; 0.080; 0.091; labelled cells: sample one: 0.096;
0.096; 0.071; sample two: 0.068; 0.052; 0.065).
Using the wound and healing assay it could be shown
that there was no negative influence on cell migration
and proliferation after SPIO labelling (P = 0.023). Fur-
thermore, it could be demonstrated that there was a
donor specific influence on cell migration and prolifera-
tion rather than an influence exerted by cell labelling.
Fig. 1 Agar phantom scanned in the T2 TSE (a) and T2 FFE (b) with histograms showing measurement of the signal intensity of regions of
interest (ROI) containing: (1) SPIO (pure Endorem); (2, 4) SPIO labelled ASCs; (3) Gadolinium MRI contrast agent (Dotarem); (5) negative control
containing agarose gel only
Fig. 2 Prussian Blue staining of SPIO-labelled canine ASCs shows blue iron particles within the cells after SPIO labelling. a Three days. b One week.
c Two weeks. d Three weeks
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Investigation of labelling efficiency via magnetic
resonance imaging
The hypointensity caused by Endorem lasted for
3 weeks in both sequences. The signal intensity for
both sequences changed within the 3 week time
period. These changes were significant (P = 0.003). A
statistical correlation between the MACS test for 1,
2 and 3 weeks and the signal intensity in the T2
TSE for 1, 2 and 3 weeks was assessed (week 1: P =
0.945; r = -0.032; week 2: P = 0.242; r = -0.510; week
3: P = 0.288; r = -0.469) and for signal intensity in the
T2 FFE (week 1: P = 0.722; r = -0.166; week 2: P =
0.619; r = -0.231; week 3: P = 0.077; r = -0.705).
The values of signal intensity in the T2w TSE and
T2w FEE for 1, 2 and 3 weeks were correlated at each
point in time (week 1: P = 0.037, r = 0.784; week 2: P =
0.006, r = 0.9; week 3: P = 0.006, r = 0.896) and for whole
time period (P < 0.001; r = 0.879).
Fig. 3 Phalloidin staining shows no alteration of the green actin filaments of the cytoskeleton after labelling (b) comparing with unlabelled
ASCs (a)
Fig. 4 Transmission electron microscopy (TEM) of SPIO labelled ASCs showing black iron inclusions (red arrows ) in the cytoplasm. a Capture of
the moment of endocytosis of SPIO into a cell and formation of a membrane vesicle. b Cluster of SPIO particles within the cytoplasm one week
after labelling. c Cluster of SPIO particles within the cytoplasm two weeks after SPIO labelling. (d) SPIO cluster within lysosomes (asterisk ) three
weeks after labelling
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It was still possible to detect all of the samples of
Endorem labelled stem cells with 1 Tesla MRI in the T2
TSE und T2 FFE sequences 3 weeks after labelling.
Discussion
The purpose of this study was the development of a
labelling strategy for tracking canine ASCs using a
clinical 1 Tesla magnetic resonance tomograph. We
evaluated the survival, differentiation potential and
tracking ability of MSCs after labelling with the con-
trast agent Endorem.
A number of labelling strategies with different contrast
agents have already been used for tracking studies;
however, these used MR scanners with a higher mag-
netic field strength, between 3 and 7 Tesla [19, 23–25].
In most veterinary facilities only low-field MRI is avail-
able. We decided to analyse stem cells over a 21 day
period of time, assuming that this time frame would be
relevant for the distribution of MSCs after clinical
application.
Because stem cell therapy has increasingly gained im-
portance for use in veterinary medicine it is essential to
develop an easy strategy for cell labelling that has no po-
tential negative influence on cell function. ASCs were
used in this study because of their uncomplicated isola-
tion and high number of MSCs in fat tissue. Incubation
Fig. 5 Red Oil O staining shows red lipid vacuoles (arrows ) in (a) Unlabelled ASCs cultured in adipogenic medium. b SPIO-labelled ASCs cultured in
adipogenic medium. c Control with unlabelled ASCs incubated in standard medium
Fig. 6 Von Kossa staining shows black stained mineralised extracellular matrix. Note also the black staining of the cell bodies. a Unlabelled
ASCs incubated in osteogenic medium. b SPIO-labelled ASCs incubated in osteogenic medium. c Control with unlabelled ASCs incubated in
standard medium
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of canine MSCs with an Endorem concentration of
319.2 μg/mL iron for 24 h resulted in sufficient uptake
and labelling of all cells. No transfection agent was used
in this study. There have been several studies using
different labelling protocols of SPIO with other concen-
trations and incubation times from 1 till 72 h. Longer in-
cubation times and higher iron concentrations resulted
in a negative influence on the labelled cells [26].
The spontaneous uptake of SPIOs from medium
containing Endorem was confirmed with PB staining
(Fig. 2a-d). Prussian blue staining is a reliable qualitative
method to show Endorem particles within the cells.
However, iron particles were not equally subdivided to
the daughter cells during cell division what caused a
substantial variation of the amount of iron particles
within a single cell. Therefore, assessment of the refer-
ence values using a 95% confidence interval was not
possible. Separation of the labelled cells from the un-
labelled cells turned out to be a reliable quantitative
method. With the aid of the MACS assay it could be
shown that the percentage of labelled canine stem cells
decreased within three weeks (P = 0.0007). Due to vari-
ation of the percentage of labelled cells it was not
possible to set reference values for MACS test. The last
two samples showed considerably lower labelling effi-
ciency. These samples were investigated at the same
time. There might be other influential factors as the
composition of the medium or incubation protocol.
However, this can be considered unlikely as we main-
tained the same condition during all parts of the study
according to the standardized protocol. Another factor
might be the variability of the stem cells behavior. As we
showed in the migration and wound healing assay the
properties of an individual cell line has a more signifi-
cant influence on the proliferation and migration than
labelling. It can be possible that these stem cells did not
incorporate SPIO particles to the same extent as other
samples or the cells incorporated the SPIO particles but
later released them into the medium.
Internalisation of the Endorem particles could also be
confirmed using TEM. One and two weeks after label-
ling the iron clusters were mostly observed distributed
within the cytoplasm (Fig. 4b, c). In contrast to that,
three weeks after labelling Endorem particles were
generally detected in the lysosomes and fewer non-
compartment bound iron clusters were seen in the
cytoplasm (Fig. 4d). This observation indicates that lyso-
somes are involved in the dissipation of Endorem and
this process starts already two weeks after labelling. Pre-
vious studies reported that cluster of iron particles are
surrounded by cell membrane structures directly after
labelling but further fate of the iron cluster was not in-
vestigated [18, 23, 27]. There were no reports about free
iron clusters within the cytoplasm. Investigation of the
exact localisation of iron particles within the cells is very
important due to the fact that their distribution is
suspected to have a significant influence on the contrast
induced signal void during the MRI examination. Larger
iron clusters are responsible for a stronger signal void
than the same amount of iron distributed evenly within
the cell [17].
Phalloidin staining showed no negative influence of
the iron particles on the cytoskeleton (Fig. 3b). This is
of great importance considering the essential role of
the cytoskeleton in migration capability and cell
division. There are reports describing a negative
Fig. 7 Alcian blue staining shows blue stained proteoglycans of the cartilage matrix. a Unlabelled ASCs cultured in chondrogenic medium underwent
completed chondrogenesis. b SPIO-labelled ASCs cultured in chondrogenic medium show chondrogenesis to a lesser extent than unlabelled
cells. c Control with unlabelled ASCs incubated in standard medium also show signs of chondrogenesis
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influence of Endorem labelling on the cytoskeleton in
rat and human MSCs using a labelling concentration
of 600 μg/mL Fe [28].
In contrast to the unaffected osteoegenic and adipo-
genic differentiation, after Endorem labelling fewer
stem cells underwent chondrogenesis compared to a
control. Other groups have come to a similar conclu-
sion: a dose dependent inhibition of chondrogenesis in
human cells was observed [29, 30]. In contrast, there
are also reports about it lacking negative influence on
cartilage formation in human cells [31]. We also ob-
served signs of chondrogenesis in the negative control.
This phenomenon has already been seen in bovine
MSCs. Three-dimensional pellet formation can lead to
spontaneous chondrogenesis [32].
It has been shown that human cells were able to pro-
liferate normally after Endorem labelling [31, 33]. Using
an MTT test and migration and wound healing assay we
could demonstrate that the proliferation of the cells after
labelling was not altered [34].
It could be shown in T2 TSE and T2 FFE sequences
that the hypointensity caused by Endorem decreased
within 3 weeks, but after this time a sufficient signal
void could still be seen in the scans. However, the results
of the statistical analysis between the percentage of la-
belled cells in the MACS test for 1, 2 and 3 weeks and
the signal intensity in the T2 TSE and T2 FFE sequences
for the same points in time showed no statistical correl-
ation. A possible explanation could be that it is not the
number of labelled cells but the intracellular distribution
of the Endorem particles that is predominantly relevant.
With the help of MACS test a differentiation between la-
belled and unlabelled cells can be made. However, the
labelled fraction can also contain cells with a low parti-
cles’ number. According to this fact that results in a high
variation of the samples, a statistical correlation is not
possible. We assumed that Endorem dissipates within
canine ASCs within a 3 week period because of cell
division and intracellular metabolism. The leakage of
iron oxide from the cell to the medium was not investi-
gated in this study but another author reported about
this issue [18]. Even if the contrast agent is spontan-
eously released by the cells there is still enough signal
void in T2 FFE and TSE caused by labelled cells after
3 weeks. However, this leakage could represent a limita-
tion for in vivo tracking studies.
The limitation of the current study is the in vitro design.
There might be a strong influence of the surrounding
structures on the migration and imaging of cells in vivo.
However, a few studies that present tracking of SPIO la-
belled cells in vivo in canine models exist. SPIO labelled
canine MSCs administered into renal artery were detect-
able as hypointense areas in the renal cortex over 8 days
at 3 Tesla [35]. Intra-arterial delivered SPIO labelled
MSCs in the canine stroke model were seen at least over
4 weeks period at 3 Tesla [36]. Also human SPIO labelled
ASCs can migrate to the site of the lesion after radiofre-
quency ablation and differentiate into cardiomyocyte-like
cells [37].
Because of the decreasing level of Endorem particles
in the cells, we assumed that the degree of signal
cancellation should decline within a 3 week period and
signal increase should be noticed. However, for the
3 week period we observed a decrease in the signal in-
tensity (Figs. 8 and 9). Considering the findings of the
TEM investigation after 3 weeks that most Endorem
particles were packed in the lysosomes (Fig. 4d) and not
distributed within the cell could be the most probable
explanation. As already mentioned, this could lead to a
stronger signal void. Other studies have also reported
that micro air deposits in the agar phantoms can cause
artefacts and strengthen the hypointense signal [18].
However, we did not observe any air inclusions in the
present study.
We chose T2 TSE and T2 FFE sequences and did not
observe relevant differences in in vitro investigation in
agar phantoms. In any case, other studies have shown
the superiority of the T2 FFE for tracking studies in vitro
and in vivo [18, 19, 38]. We decided to use also T2 TSE
as this is a standard sequence superior to T2 FFE con-
cerning the clinical use due to the clear depiction of the
anatomy with high contrast between different soft tis-
sues. The aim was to investigate whether the influence
of the iron oxides is strong enough to influence also the
T2 spin echo signal. The advantage of an investigation
using the T2 TSE sequence would be the picture of the
anatomy and assessment of the iron distribution at the
same time. However, T2 FFE sequences are more sensi-
tive regarding the paramagnetic properties of the iron
oxide nanoparticles. This is why the T2 FFE sequence
should be the method of choice to detect Endorem
labelled stem cells.
Fig. 8 Development of the signal intensity in the T2 TSE sequence
for all samples one, two and three weeks after labelling
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Conclusion
An Endorem labelling concentration of 319.2 μg/mL Fe
(448 μg/mL SPIO) had no adverse effects on the viability
of canine ASCs. After a 3 week period of culture
Endorem labelled ASCs were detectable with a 1 Tesla
magnetic resonance tomograph in T2w TSE and T2wFFE
sequences. Therefore, this contrast agent could be used as
a model for iron oxide labelling agents. However, the
tracking ability in vivo has to be evaluated in further
studies. A potential influence on chondrogenesis should
be further investigated.
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